pharmaphorum

MARCH 8, 2024

In another inflection point for the psychedelic medicines category, Mind Medicine (MindMed) has claimed breakthrough status from the FDA for its LSD-based treatment candidate MM120 as a treatment for anxiety.

104

104

PharmaShots

FEBRUARY 3, 2023

4D Molecular Therapeutics Receives the US FDA’s IND Clearance of 4D-150 for the Treatment of Diabetic Macular Edema Date: Feb 03, 2023 | Tags: 4D Molecular Therapeutics, 4D-150, Diabetic Macular Edema, Regulatory, US, FDA, IND AstraZeneca and Amgen Receive the US FDA’s Approval of Tezspire (tezepelumab) for the Treatment of Severe Asthma (..)

Biosimilars 40

Biosimilars Diabetes Labelling 40

pharmaphorum

JANUARY 11, 2022

The DTx, called BNT200, is described as a first-of-its-kind DTx to treat anxiety and depression in adults with acute myeloid leukaemia (AML) who are hospitalised for a regimen of high-intensity induction chemotherapy. The post Blue Note leukaemia DTx gets FDA breakthrough tag appeared first on.

Chemotherapy 64

Chemotherapy Hospitals 64

pharmaphorum

OCTOBER 21, 2021

Vounatsos also insisted that Aduhelm’s price tag has not been a factor discouraging treatment with the drug. Pushback from doctors in particular is causing anxiety for investors, as that may not be affected much if CMS opts to approve reimbursement, and shares in the company fell a little over 6% following the results announcement.

122

122

RX Note

FEBRUARY 9, 2024

Anxiety 焦虑 - A feeling of worry, unease or nervousness that varies from mild to severe. Skin tags 皮赘 - Small, soft, skin-coloured growths on your skin. Aphasia 失语症 - Difficulty speaking or understanding language; can be due to a stroke, head injury, brain tumour. It is usually caused by cold or allergies. Somnolence 睡意 - Sedation.

Immunity 40

Immunity Immunization Diabetes Communication 40